INTRODUCTION: Ischemia-modified albumin (IMA) has been proposed as a useful rule-out
marker for the diagnosis of acute coronary syndrome (ACS) in the emergency department …

BACKGROUND: The aim of this study was to retrospectively evaluate the utility of assessing
ischemia-modified albumin (IMA) levels for diagnosing acute coronary syndrome (ACS) in …

Background Diagnosis of acute coronary syndrome (ACS) is important, due to the
associated very high mortality. Failure to diagnose ACS is a problem both for the patients …

Ischemia modified albumin (IMA) is a relatively new marker for evaluating patients with
cardiac ischemia. Data are emerging on its potential role in non-cardiac ischemic events. In …

BACKGROUND: The diagnosis of myocardial ischemia in patients with acute chest pain at
rest but non-diagnostic electrocardiograms (ECG) is problematic. Ischemia Modified …

Background: Ischemia-modified albumin (IMA) has been suggested as a marker of cardiac
ischemia. Little, however, is known about its capacity to predict short-term serious cardiac …

The diagnostic usefulness of ischemia-modified albumin in acute coronary syndrome (ACS)
has been questioned. The goal of this systematic review and meta-analysis was to see how …

Background: Ischemia-modified albumin has been proposed as a useful rule-out marker for
the diagnosis of acute coronary syndrome in the emergency department. Objective: To …

BACKGROUND: Patients with acute chest pain remain a great diagnostic challenge to
emergency physicians. Ischemia-modified albumin (IMA) is a recently developed biomarker …

Background: Diagnosis of cardiac ischaemia in patients attending emergency departments
(ED) with symptoms of acute coronary syndromes is often difficult. Cardiac troponin (cTn) is …